Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$1.24M Sell
31,932
-67,253
-68% -$2.58M 0.05% 360
2017
Q1
$3.87M Buy
99,185
+76,326
+334% +$3.08M 0.19% 147
2016
Q4
$872K Buy
+22,859
New +$849K 0.07% 263
2016
Q2
Sell
-41,097
Closed -$1.91M 920
2016
Q1
$1.91M Buy
41,097
+28,026
+214% +$1.35M 0.13% 180
2015
Q4
$707K Buy
+13,071
New +$629K 0.05% 375
2014
Q4
Sell
-184,497
Closed -$8.39M 931
2014
Q3
$8.39M Buy
184,497
+79,117
+75% +$3.85M 0.57% 36
2014
Q2
$5.43M Buy
105,380
+78,788
+296% +$3.87M 0.45% 53
2014
Q1
$1.3M Buy
+26,592
New +$1.29M 0.23% 140
2013
Q3
Sell
-50,002
Closed -$1.55M 667
2013
Q2
$1.55M Buy
+50,002
New +$1.49M 0.23% 104

Other funds holding VTRS

Airain Ltd's VTRS Position: Q2 2017 in Review

Airain Ltd reduced its Viatris (VTRS) stake by 68% in Q2 2017, selling an estimated $2.58M and leaving 31,932 shares worth $1.24M. The position accounts for 0.05% of the portfolio, ranked #360.

Airain Ltd first reported a position in VTRS in Q2 2013 and has held it in 9 quarters since. The position peaked at $8.39M in Q3 2014. 537 funds tracked by Wall St. Rank hold VTRS as of Q2 2017.

  • Airain Ltd held 31,932 shares of Viatris worth $1.24M as of Q2 2017.
  • Airain Ltd sold 67,253 Viatris shares in Q2 2017, an estimated $2.58M.
  • Viatris made up 0.05% of Airain Ltd's portfolio in Q2 2017, its #360 holding.
  • Airain Ltd first reported a position in Viatris in Q2 2013 and has held it in 9 quarters since.
  • Airain Ltd's Viatris position peaked at $8.39M in Q3 2014.
  • 537 funds tracked by Wall St. Rank held Viatris as of Q2 2017.

Based on Airain Ltd's 13F filing for Q2 2017, filed 8 Aug 2017.